glp 1 neuroprotection Neuroprotective Mechanisms of GLP-1 Receptor Agonists in Visual representation of the beneficial

[DOI] [PubMed] [Google Scholar] 122.Fiore M., Cristaldi A., Okatyeva V., Lo Bianco S., Oliveri Conti G., Zuccarello P., Copat C., Caltabiano R., Cannizzaro M., Ferrante M

However, it is important to note that the information provided here is not intended as medical advice

Book this service now

The strength of correlation between maximum CMAP amplitude and our primary outcome measure, the MHFMS, suggests that in non-ambulatory patients with SMA the CMAP may be a robust surrogate outcome measure for assessing treatment interventions if the putative mechanism of effect is to enhance innervated muscle mass by reinnervation or other trophic effects on nerve or muscle